Provided by Kevin M. Farrell
Kevin Farrell is Chair of the firm's Patent Practice Group. In this role he is involved strategically in the formulation of claims, development of applications, and client counseling. His practice also includes due diligence analysis in connection with financing, merger and acquisition activity, as well as the preparation of opinions relating to patents and patent applications. Kevin's historical practice dates back to the late 1980's with an emphasis on biotechnology-related inventions. He has represented some of the nation's leading academic institutions, as well as corporate clients ranging from start-ups to Fortune 500 companies.
Kevin brings to his legal practice hands-on experience in recombinant DNA techniques, such as nucleic acid cloning, and experience gained in technical positions at both Harvard Medical School and Repligen Corporation.
Boston Patent Law Association; American Intellectual Property Law Association; Licensing Executives Society; Biotechnology Association of Maine (past president); Board of Directors of the New Hampshire Biotechnology Council.
J.D., Northeastern University School of Law; B.S. (Biology), Boston College.
Kevin Farrell of Pierce Atwood LLP leads the firm's patent practice and attracts a range of corporate entities and academic institutions with his longstanding experience. He advises on transactional due diligence as well as prosecutions, with notable strength in biotechnology mandates.